KLF6 expression attenuates the tumorigenicity of glioblastoma multiforme cells both in vitro and in vivo and is able to inhibit cellular transformation induced by a variety of oncogenes (Kimmelman et al., 2004). This evidence concerns the gene KLF6 and glioblastoma.